Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Apollo Global Management Ord Shs (APO) vs Humana Inc (HUM) Price & Performance

Apollo Global Management Ord Shs
Humana Inc

Price performance

Price movement over the last 24 hours

Key statistics

Apollo Global Management Ord Shs vs Humana Inc — how do they compare? Apollo Global Management Ord Shs trades at $120 (market cap $69.38B), while Humana Inc trades at $399.94 (market cap $47.09B). The key difference: Apollo Global Management Ord Shs is the larger of the two by market cap, and Apollo Global Management Ord Shs pays the higher dividend (1.87%). Which is the better fit depends on your goals.

APOHUM
Market Cap
$69.38B$47.09B
Sector
FinancialsHealth
52-Week High
$156.05$409.42
52-Week Low
$100.30$163.67
Enterprise Value
-$168.19B$56.13B
Dividend Yield
1.87%0.9%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Apollo Global Management Ord Shs

Apollo Global Management (APO) trades at $120.34, up 0.42% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported Q1 2026 EPS of $1.94, beating estimates, and maintains strong analyst support with 23 buy ratings. Recent news highlights private credit growth opportunities alongside liquidity concerns in Apollo's funds.

APO's outlook is supported by earnings beats and a $149.86 consensus price target, but risks include private credit liquidity pressures and a high P/E ratio of 75.69. Investor sentiment is mixed due to ongoing fund withdrawal caps and legal investigations, though long-term growth in alternative assets remains a positive catalyst.

Humana Inc

Humana (HUM) trades at $392.22, down 1.39% on the day, with technical indicators showing a bullish trend despite near-term overbought signals. The company reported revenue growth to $129.66 billion in 2025 but faces margin compression, with net income margin declining to 0.82%. Recent news highlights strategic shifts, including the $900 million divestiture of its Gentiva stake and expansion of Medicaid contracts, while legal investigations into fiduciary duties and healthcare cost disclosures present headwinds.

The stock's outlook is mixed: bullish technicals and revenue growth contrast with margin pressures and legal risks. Analysts are cautious, with a consensus price target of $327.07 below the current price, suggesting limited upside. Investment opportunities lie in Humana's strategic focus on profitability and CenterWell growth, but risks include regulatory scrutiny and execution challenges in a competitive healthcare landscape.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Apollo Global Management Ord Shs

Apollo Global Management Inc is an alternative investment manager. It serves various sectors such as chemicals, manufacturing and industrial, natural resources, consumer and retail, consumer services, business services, financial services, leisure, and media and telecom and technology. The company operates in three business segments that are Private Equity, Credit, and Real Assets. It generates maximum revenue from the Credit segment in the form of fees. The credit segment primarily invests in non-control corporate and structured debt instruments including performing, stressed and distressed instruments across the capital structure. It also includes Corporate Credit

Read more on APO

About Humana Inc

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Read more on HUM